Skip to main content
Clinical Trials/PACTR202311873054587
PACTR202311873054587
Not yet recruiting
Phase 3

Role of Probiotics as Adjuvant Therapy in Newly Diagnosed Immune Thrombocytopenia in Children

Faculty of Medicine Tanta University0 sites60 target enrollmentNovember 7, 2023

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Haematological Disorders
Sponsor
Faculty of Medicine Tanta University
Enrollment
60
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 7, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Children aged 1–18 years with primary ITP having platelet count \<30,000 /µL

Exclusion Criteria

  • Patients with secondary ITP including leukemia, drugs, lupus erythematous, cirrhosis, HIV, hepatitis C, antiphospholipid syndrome, von\-Willebrand factor deficiency.
  • Previous probiotic or antibiotic treatment for the past 4 weeks.

Outcomes

Primary Outcomes

Not specified

Similar Trials